Highline Capital Management, L.P. / RCKT
Highline Capital Management, L.P.’s Rocket Pharmaceuticals Inc Position
Does Highline Capital Management, L.P. own Rocket Pharmaceuticals Inc (RCKT)? Not currently — the last reported position was 77.4K shares worth $4M in Q4 2020; the fund’s latest 13F (Q4 2022) no longer reports it.
Position Value
$4M
Q4 2020
Shares
77.4K
% of Portfolio
+2.08%
Quarters Held
1
position exited
Position History RCKT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2020 | 77.4K | $4M | +2.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highline Capital Management, L.P.’s full portfolio or all institutional holders of RCKT.